Topic
Multipolar World Risks: Geopolitical & Policy Investment Reports
The global landscape is currently defined by a massive, supply-constrained AI buildout, with capital expenditure projected to reach between $990 billion and $1 trillion annually by 2028. This rapid technological expansion is occurring alongside significant geopolitical shifts, including a notable rightward pivot in Colombian politics toward fiscal consolidation and persistent cynicism regarding US-Iran relations that keeps oil prices elevated. In the Middle East, potential de-escalation provides temporary market relief, yet structural risks to energy security via the Strait of Hormuz remain a primary concern for long-term stability. Consequently, institutional research advocates for broadening equity exposure beyond US mega-caps into regions like Japan and China, while diversifying across AI intelligence and application layers to mitigate the risk of incumbent displacement. Furthermore, widespread policy uncertainty is cooling business investment in both Japan and the US factory sector, prompting a tactical shift toward active management and private markets. Ultimately, investors are encouraged to balance enthusiasm for AI beneficiaries with defensive strategies in high-quality government debt and global healthcare to navigate these multifaceted multipolar risks.
6108 reports available
All reports
Page 255 of 255
Equity Positioning and Key Levels
Goldman Sachs · Apr 13, 2026
March and Q1 2026 Performance Review
Deutsche Bank · Apr 1, 2026
Investment Strategy Quarterly
Raymond James · Apr 1, 2026
Markets and Macro
Goldman Sachs · Mar 29, 2026
Good Morning Mail
Goldman Sachs · Mar 25, 2026
Sentiment Positioning Late Cycle Tightening and Long Term Oil
Goldman Sachs International · Mar 14, 2026
Global Equities Call
Goldman Sachs · Mar 10, 2026
TMT Special Sales: Nvidia and Indra Beat, WPP Strategy, and Tech Conference Wrap
Goldman Sachs · Feb 26, 2026
When Tangible Wins
Goldman Sachs · Feb 20, 2026
Tactical Short: Expensive Defensives and Staples
Goldman Sachs & Co. LLC · Feb 20, 2026
Illuminating the Road Less Traveled in Biotech: Radiopharmaceuticals
William Blair · Jan 8, 2026
Supply and Cash Flow Monitor
Crédit Agricole Corporate and Investment Bank · Oct 25, 2024